Description

BSE lists new privately placed commercial paper from 360 ONE Alternates, Vivriti Capital, Standard Chartered Securities, and debt securities from Liquid Gold Series 17, effective January 5, 2026.

Summary

BSE has admitted new privately placed securities to trading on its Debt Segment effective January 5, 2026. The listing includes three commercial paper issuances totaling Rs. 570 crores and two debt instrument series from Liquid Gold Series 17. All securities will trade in dematerialized form only.

Key Points

  • Three commercial paper issuances listed: 360 ONE Alternates Asset Management (240 units), Vivriti Capital (800 units), and Standard Chartered Securities India (200 units)
  • Two debt securities from Liquid Gold Series 17 listed: 9,546 units at 8.42% p.a. and 354 units at 9.57% p.a.
  • All commercial papers have face value of Rs. 5 lakhs each with standard lot size
  • Commercial papers carry A1+ credit ratings from CARE, CRISIL, and ICRA
  • Trading commenced on January 5, 2026
  • Standard denomination of Rs. 5 lakhs applies to commercial papers with tick size of 1 paise

Commercial Paper Details

360 ONE Alternates Asset Management Limited

  • Quantity: 240 units (Scrip Code: 730887)
  • Issue Price: Rs. 4,72,827.50
  • Interest Rate: 7.60% p.a. (cumulative)
  • Redemption Date: October 5, 2026
  • ISIN: INE0TQI14012
  • Rating: CARE A1+

Vivriti Capital Limited

  • Quantity: 800 units (Scrip Code: 730888)
  • Issue Price: Rs. 4,82,005.00
  • Interest Rate: 9.27% p.a. (cumulative)
  • Redemption Date: May 29, 2026
  • ISIN: INE01HV14AJ2
  • Rating: CRISIL A1+

Standard Chartered Securities (India) Limited

  • Quantity: 200 units (Scrip Code: 730889)
  • Issue Price: Rs. 4,91,994.00
  • Interest Rate: 6.6% p.a. (cumulative)
  • Redemption Date: April 2, 2026
  • ISIN: INE472H14763
  • Rating: ICRA A1+

Debt Securities Details

Liquid Gold Series 17 - Tranche 1

  • Quantity: 9,546 units (Scrip Code: 977436)
  • Face/Issue Price: Rs. 1,00,000
  • Interest Rate: 8.42% p.a. (monthly payment)
  • Allotment Date: December 31, 2025
  • Redemption Date: April 20, 2028
  • ISIN: INE2PA615015
  • Rating: CRISIL AA+(SO)

Liquid Gold Series 17 - Tranche 2

  • Quantity: 354 units (Scrip Code: 977437)
  • Face/Issue Price: Rs. 1,00,000
  • Interest Rate: 9.57% p.a. (monthly payment)
  • Allotment Date: December 31, 2025
  • ISIN: INE2PA615023
  • Rating: CRISIL A(SO)

Compliance Requirements

  • All securities must be traded only in dematerialized form
  • Commercial paper trading in standard denomination of Rs. 5 lakhs and multiples
  • Market lot size is 1 unit for all listed securities
  • Tick size of 1 paise applies to all instruments
  • Trading members requiring clarifications should contact BSE debt department at 22728352/8597/8995/5753/8915

Important Dates

  • January 2, 2026: Allotment date for all three commercial paper issuances
  • January 5, 2026: Trading commencement date for all listed securities
  • December 31, 2025: Allotment date for Liquid Gold Series 17 debt securities
  • April 2, 2026: Redemption date for Standard Chartered Securities CP
  • May 29, 2026: Redemption date for Vivriti Capital CP
  • October 5, 2026: Redemption date for 360 ONE Alternates CP
  • April 20, 2028: Redemption date for both Liquid Gold Series 17 tranches

Impact Assessment

This is a routine listing notification with minimal market impact. The listing expands the debt market segment with investment-grade commercial paper and structured debt instruments. Commercial papers offer short-term investment options (3-9 months tenure) with competitive yields ranging from 6.6% to 9.27% p.a. The Liquid Gold Series 17 debt securities provide longer-term investment opportunities (approximately 2.3 years) with monthly interest payments and higher ratings. Trading members can now access these instruments for client portfolios requiring fixed-income exposure. No impact on equity markets or existing listed securities.

Impact Justification

Routine listing notification for privately placed debt securities with no impact on equity markets or broader regulatory framework